The handbook of global health policy / edited by Garrett W. Brown, Gavin Yamey, and Sarah Wamala ; Ashkan Afshin [and sixty three others], contributors.

1st edition
  • Chichester, England : Wiley-Blackwell, 2014.
  • ©2014
1 online resource (767 p.)


Summary note
  • "The Handbook of Global Health Policy provides a definitive source of the key areas in the field. It examines the ethical and practical dimensions of new and current policy models and their effect on the future development of global health and policy. Maps out key debates and policy structures involved in all areas of global health policy Isolates and examines new policy initiatives in global health policy Provides an examination of these initiatives that captures both the ethical/critical as well as practical/empirical dimensions involved with global health policy, global health policy formation and its implications Confronts the theoretical and practical questions of 'who gets what and why' and 'how, when and where?' Captures the views of a wide array of scholars and practitioners, including from low- and middle-income countries, to ensure an inclusive view of current policy debates "-- Provided by publisher.
  • "Provides a state-of-the-art guide to global health and its associated policies, mapping out key debates, new initiatives, and policy structure"-- Provided by publisher.
Includes index.
Bibliographic references
Includes bibliographical references at the end of each chapters and index.
Source of description
Description based on print version record.
Language note
  • Intro
  • Series
  • Titlepage
  • Copyright
  • Notes on Contributors
  • Foreword: Global Health Policy-Making in Transition
  • References
  • Acknowledgments
  • Introduction
  • Why Global Health Policy
  • The State of the World's Health
  • A New Kind of Handbook to Guide Action on these Challenges
  • Five Key Themes Emerging from the Book
  • Conclusions
  • Part I Global Health Policy and Global Health Governance
  • 1 Understanding Global Health Policy
  • Globalization and the Transformation of Global Health Policy
  • New Global Health Policy Actors
  • Global Health Policy Instruments and Levers
  • Contribution of Theory to Understanding Global Health Policy
  • Conclusions and Pointers for the Health Policy Analyst
  • 2 Critical Reflections on Global Health Policy Formation: From Renaissance to Crisis
  • From Renaissance to Crisis
  • How can the Crisis in Global Health be Explained?
  • Critical Understandings of Policy Formation
  • Overcoming the Four Rs: Recommendations
  • 3 Contemporary Global Health Governance: Origins, Functions, and Challenges
  • What is Global Health Governance?
  • What Purpose does Global Health Governance Serve?
  • Key Functions of Global Health Governance
  • Major Developments in International Health Institutions: New Players and New Priorities
  • The Current Crisis in Global Health Governance
  • 4 Global Health Justice and the Right to Health
  • Debates about Health Justice at the Domestic Level
  • Limiting the Scope of Health Justice to the State
  • Cosmopolitanism and Broadening the Scope of Health Justice
  • Rights-Based Approaches to Health: Problematizing the Use of Rights Claims to Promote Social Justice at the Domestic and Global Level
  • References.
  • Part II Narrowing the Gap Between Knowledge and Action
  • 5 Measuring the World's Health: How Good are Our Estimates?
  • What are Health Metrics, and Why do They Matter to Global Health Policy?
  • Metrics for the World's Health
  • Data Sources for the World's Health Metrics
  • From Producing Health Metrics to Informing Policy: Are Our Estimates Good Enough?
  • Moving Towards Better Health Estimates
  • 6 Achieving Better Global Health Policy, Even When Health Metrics Data are Scanty
  • What is Global Health Policy - and What Health Metrics Data are Needed?
  • Scale of Health Metrics Data
  • Population Basis of Health Metrics Data
  • Linking Health Service Encounters with the Everyday Lives of Citizens
  • Uncertainties in Measuring Health
  • Ethical Issues in Health Metrics Data
  • Moving from Health Metrics Data to Health Policy
  • 7 An Argument for Evidence-Based Policy-Making in Global Health
  • Narrowing the Gap
  • Why Should We Use Evidence? Which Evidence Should We Use?
  • Using Different Types of Evidence to Answer Different Questions
  • Evidence-Informed Policies Improve Public Health
  • What are the Barriers to EBP in Global Health?
  • The New Landscape of Evidence Translation in Global Health
  • 8 Can Global Health Policy be Depoliticized? A Critique of Global Calls for Evidence-Based Policy
  • Understanding Evidence-Based Global Health Policy
  • The Pejorative Influence of Politics in Global Health Policy
  • Producing Health Sciences Research: The Politics of Creating the Evidence Base
  • Using Health Sciences Research: What to Value and How to Value Evidence in Decision-Making
  • Wider Implications of a Depoliticized Approach to Evidence
  • Conclusions: A Way Forward?
  • Part III The Politics of Risk, Disease, and Neglect
  • 9 Dietary Policies to Reduce Non-Communicable Diseases
  • The Policy Problem
  • The Policy Solution
  • The Next Steps
  • 10 Ethical Reflections on Who is At Risk: Vulnerability and Global Public Health
  • What is a Risk?
  • What does it Mean to be Vulnerable?
  • Vulnerability, Responsibility, and Moral Obligations
  • Notes
  • 11 Ethical and Economic Perspectives on Global Health Interventions
  • Hidden and Long-Term Returns to Disease Mitigation
  • Health, Justice, and Global Institutions
  • 12 Global Health Policy Responses to the World's Neglected Diseases
  • What is a Neglected Disease?
  • Why are They Neglected?
  • The Decade of Change
  • Policy Responses to Neglected Disease R&
  • D
  • Debates and Controversies
  • 13 The Fight for Global Access to Essential Health Commodities
  • The Medical Innovation System is Failing Many Patients
  • The First Problem: Medical Tools are Often Priced Out of Reach
  • The Second Problem: Medical Tools to Address "Unprofitable" Diseases are Often Unavailable
  • The Third Problem: Medical Tools are Often Unsuitable for Neglected Populations
  • How to Ensure Better Access to More Appropriate Innovation
  • Innovation and Access: Towards a System that Delivers what Patients Need
  • Acknowledgment
  • 14 The Social Determinants of Health
  • A Brief Genealogy of the SDH Approach
  • Some Conceptual Clarifications
  • Evidence Base for the Importance of SDHs
  • Globalization of Production and Finance: Undermining SDHs?
  • Part IV Diplomacy, Security, and Humanitarianism.
  • 15 Arguments for Securitizing Global Health Priorities
  • Securitization of Infectious Disease in the Post-Cold War World
  • Reasons to Welcome the Securitization of Health
  • 16 Viral Sovereignty: The Downside Risks of Securitizing Infectious Disease
  • Method
  • Results and Discussion
  • 17 The Changing Humanitarian Sector: Repercussions for the Health Sector
  • The Changing Nature of Humanitarian Crises
  • Humanitarian Aid Architecture
  • Adjusting to a Diverse and Fast-Changing World
  • Preparing for Future Humanitarian Crises
  • Conclusion: Challenges and Opportunities Ahead
  • 18 The Limits of Humanitarian Action
  • Limits of Humanitarian Action
  • Quantitative and Qualitative Limits
  • External and Internal Barriers
  • Five Main Types of Limit
  • Part V Financing and the Political Economy of Global Health
  • 19 The Global Health Financing Architecture and the Millennium Development Goals
  • Progress Towards the Health MDGs
  • Trends in Global Health Financing
  • Key Players in the Global Health Financing Architecture: the Emergence of New Financing Institutions
  • The Need for Domestic Financing
  • Improving the Quality and Efficiency of Global Health Financing
  • Increased Accountability
  • Looking Forward: Lessons Learned and Recommendations
  • 20 Can International Aid Improve Health?
  • Examining the Evidence
  • The Economic Way of Thinking
  • Incentives
  • Information
  • 21 The Exterritorial Reach of Money: Global Finance and Social Determinants of Health
  • Implicit Conditionalities
  • Capital Flight
  • The Crisis of 2008
  • Evidence on Health Outcomes.
  • Conclusions and Policy Implications
  • 22 Trade Rules and Intellectual Property Protection for Pharmaceuticals
  • Trade Rules and Intellectual Property Protection for Pharmaceuticals
  • Pharmaceutical Patents Before and After TRIPS
  • Pharmaceuticals Post-TRIPS and the "IP Access to Medicines" Contests
  • PTAs and "TRIPS Plus" Pharmaceutical Standards
  • Looking Ahead - Some Concluding Thoughts
  • 23 The Health Systems Agenda: Prospects for the Diagonal Approach
  • A Conceptual Base for Health Systems
  • The Diagonal Approach
  • The Diagonal Approach in Practice: Lessons from Mexico
  • 24 Will Effective Health Delivery Platforms be Built in Low-Income Countries?
  • First Decade of the "Global Health Revolution": Where Did All the International Assistance Go?
  • Why was Development Assistance for Health Allocated to Infectious Disease Control?
  • Preliminary Conclusion: An Opportunity for Integrating Infectious Disease Control with Health Systems Strengthening
  • Infectious Disease Control Programs Building Health Delivery Platforms: Diagonal Approach, Bottom-Up and Top-Down
  • Part VI Health Rights and Partnerships
  • 25 A Rights-Based Approach to Global Health Policy: What Contribution can Human Rights Make to Achieving Equity?
  • The Right to Health in International Human Rights Law
  • Critiques and Weaknesses of Human Rights and Right to Health
  • Contribution of Human Rights to Global Health Equity
  • A Way Forward: Defining a Research Agenda for Global Health and Human Rights
  • 26 From Aid to Accompaniment: Rules of the Road for Development Assistance
  • From Aid to Accompaniment
  • 27 Global Health Partnerships: The Emerging Agenda.
  • 1-118-50961-7
  • 1-118-50962-5
  • 1-118-50963-3
  • 1-118-50960-9
  • 876512945
  • 908032129
Statement on language in description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...
Other views
Staff view